22 May 2025
It was a happy coincidence: the final text of the Recommendations of the Multidisciplinary and Multiprofessional Working Group on the Clinical Use of Psychedelic Substances was released on the same day that the Portuguese National Health System announced its decision to fully reimburse the treatment of resistant depression with a substance called esketamine.
20 May. 2025
We are seeking a highly motivated and skilled Post-Doctoral Fellow to join our dynamic research team at the Botton-Champalimaud Pancreatic Cancer Centre. This prestigious center is dedicated to advancing pancreatic cancer research and treatment through innovative approaches and multidisciplinary collaboration. The successful candidate will contribute to cutting-edge research aimed at understanding the molecular, metabolic and immune mechanisms of pancreatic cancer progression and developing novel therapeutic strategies.
19 May. 2025
A Call for one research fellowship (Bolsa de Investigação) for a Game/VR Developer is open at Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation) in the context of the project entitled “Research Infrastructure for Digital Therapeutics”, with reference “LISBOA2030-FEDER-01316800” from the call Nº “LISBOA2030-2024-15”, funded by the: European Regional Development Fund (ERDF), through the Lisbon Regional Programme 2021-2027.
14 May 2025
Sian Harding, a world leader in cardiac research, joins Hedi to reveal the heart as you’ve never seen it before, as they discuss her book The Exquisite Machine: The New Science of the Heart. From how social rank, air pollution, noise, and even your mother’s pregnancy diet can shape heart health, to the heart’s mini-brain or growing hearts in the lab from skin cells, they uncover the remarkable ways this muscular organ does far more than “just” pump blood.
08 May. 2025
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for Post-Doctoral to join our team at the Champalimaud Research Programme.
08 May 2025
An international team, led by researchers at the Champalimaud Foundation (CF), has shown – for the first time in a realistic way – that it may be possible, in the future, to diagnose Parkinson’s disease (PD) years earlier, by scanning people’s brains with functional magnetic resonance imaging (fMRI). Although there are treatment options after diagnosis, there is no cure. Therapies are continually improving — with ongoing research aiming to slow or even alter the course of the disease - investing in the research of methods that enable much earlier diagnosis is crucial.